Nasdaq IPOs

Brilliant Acquisition, a blank check company targeting an Asia Pacific business, filed on Friday with the SEC to raise up to $40 million in an initial public offering.  The Shanghai, China-based company plans to raise $40 million by offering 4 million units at a price o

Since February 21, 2020, the S&P 500 has shed 18%, while the Renaissance IPO Index is down 17%. Of all 734 active IPOs since 2015, just 36% are trading above issue, and only 8% have positive returns since late February. Of these IPOs, the top performers are mainly bio

Imara, a Phase 2 biotech developing small molecule therapies for rare genetic disorders, raised $75 million by offering 4.7 million shares at $16, the low end of the range of $16 to $18, to command a $286 million fully diluted market cap. Imara plans to list on the Nasdaq under

Imara, a Phase 2 biotech developing small molecule therapies for rare genetic disorders, raised $71 million by offering 4.5 million shares at $16, the low end of the range of $16 to $18, to command a $283 million fully diluted market cap. Imara plans to list on the Nasdaq under

DFP Healthcare Acquisitions, the second healthcare-focused blank check company formed by Deerfield Management and Robert Barasch, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-quarter of one warrant exercisable a

We entered 2020 expecting an active IPO market from March to July, due to the depth of the pipeline and strong returns in the prior year. However, volatility from the coronavirus outbreak has now essentially shut down the spring IPO market. With admitted uncertainty, we expect

Record-high volatility and investor uncertainty have weighed on the IPO market in recent weeks, but blank check activity is as high as ever, indicating another banner year for the acquisition vehicles. So far in 2020, 19 SPACs have submitted initial filings with the SEC, a 111

Atotech, a Carlyle-backed specialty chemicals company carved out of Total, reported financial results for the fiscal year ended December 31, 2019, in an amendment filed with the SEC on Monday. It originally filed for an IPO in January 2020 with a deal size Renaissance Capital es

Chardan Healthcare Acquisition 2, the second blank check company formed by Chardan Capital targeting the healthcare industry, filed on Monday with the SEC to raise up to $85 million in an initial public offering. The New York, NY-based company plans to raise $85 million by offer

Facing record-high volatility and market uncertainty, one biotech is scheduled for the week ahead. Formed by New Enterprise Associate’s orphan drug accelerator Cydan, genetic disorder biotech Imara (IMRA) plans to raise $76 million at a $301 million market cap. The Bo

A billion-dollar IPO and two SPACs entered the market this past week, and four IPOs and five SPACs submitted initial filings. The VIX volatility index is still at record-high levels and the turbulent market environment shows no signs of steadying just yet. Waste giant G

CC Neuberger Principal Holdings I, a blank check company formed by CC Capital and Neuberger Berman, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans to raise $300 million by offering 30 million

Lyra Therapeutics, a Phase 2 biotech targeting ear, nose, and throat diseases, filed on Friday with the SEC to raise up to $58 million in an initial public offering. The Watertown, MA-based company was founded in 2005 and plans to list on the Nasdaq under the symbol LYRA. BofA S

Zentalis Pharmaceuticals, a Phase 1/2 biotech developing novel small molecule therapies for various cancers, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company currently has three product candidates in Phase 1/2 trials and has rai

Albertsons Companies, a US grocer operating under Albertsons, Safeway, and other banners, filed on Friday with the SEC to raise up to $100 million in an initial public offering, though this is likely a placeholder for a deal we estimate could raise up to $2 billion. The

Ayala Pharmaceuticals, a Phase 2 biotech developing small molecule therapies for aggressive cancers, filed on Friday with the SEC to raise up to $50 million in an initial public offering.  The Rehovot, Israel-based company was founded in 2017 and booked $2 million in li

Fortress Value Acquisition, a blank check company formed by executives at Fortress Investment Group, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans to raise $300 million by offering 30 million units at

LifeSci Acquisition, a blank check company formed by LifeSci Capital targeting the healthcare industry, raised $60 million by offering 6 million units at $10 at a market cap of $73 million. The company originally planned to offer 5 million units. Each unit consists of one share

Flying Eagle Acquisition, the sixth blank check company formed by SPAC veteran Jeff Sagansky and former MGM CEO Harry Sloan, raised $600 million by offering 60 million units at $10 to command a market value of $750 million. Each unit consists of one whole share of common stock a

Safe Auto Insurance Group, a direct-to-consumer auto insurance provider, withdrew its plans for an initial public offering on Thursday. It originally filed in May 2019 with a proposed deal size of $50 million. The Columbus, OH-based company was founded in 1993 and booked $436 mi